Alonso Torres AM, Arévalo Bernabé AG, Becerril Ríos N, Hellín Gil MF, Martínez Sesmero JM, Meca Lallana V, Ramió-Torrentá L, Rodríguez-Antigüedad A, Gómez Maldonado L, Gómez-Barrera M, Espinoza N, Oyagüez I
Cost-analysis of subcutaneous versus intravenous administration for natalizumab in Multiple Sclerosis in Spain
8th European Academy of Neurology (EAN) Congress. Viena. 25-28 jun 2022
Mareque M, Climente M, Martínez E, Padilla A, Oyagüez I, Touron C, Torres C
Cost-effectiveness of benralizumab in patients with uncontrolled severe eosinophilic asthma in Spain
European Respiratoy Society International Congress. Barcelona. 04-06 sep 2022
Buti M, Calleja JL, Rodríguez MÁ, Cantero H, de las Heras A, Domínguez-Hernández R, Casado MÁ
Bulevirtide avoids future clinical events and related costs compared to pegylated-interferon alpha in chronic hepatitis D in Spain
International Liver Congress (EASL). London. 22-26 jun 2022
Esteban R, Domínguez-Hernández R, Cantero H, Casado MA
Evaluation of the clinical and economic value of sofosbuvir / velpatasvir (SOF / VEL) in patients with chronic hepatitis C in Spain during the last 5 years
International Liver Congress (EASL). London. 22-26 jun 2022
Alonso JC, Casans I, González FM, Fuster D, Rodríguez A, Sánchez N, Oyagüez I, Burgos R, Williams AO, Espinoza N
Economic evaluations of radioembolization with itrium-90 microspheres in hepatocellular carcinoma: a systematic review
BMC Gastroenterol. 2022 Jul 2;22(1):326
Hernández R, Rando-Segura A, Riveiro-Barciela M, Rodríguez-Frías F, Barreira A, Palom A, Casado MA, Esteban R, Buti M